Histide

Description: Histide pioneers non-mutagenic Cell Recoding Molecules™ (CRMs) for Recoding Therapeutics™, targeting untreatable diseases via extracellular signaling.

Country: Switzerland

Based in: Schindellegi

Founded: 2014

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Medical', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.